| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.10▼ | 1.11▼ | 1.10▼ | 1.08▼ | 1.10▼ |
| MA10 | 1.10▼ | 1.09▼ | 1.09▼ | 1.08▼ | 1.10▼ |
| MA20 | 1.09▼ | 1.08▲ | 1.08▲ | 1.07▲ | 0.98▲ |
| MA50 | 1.08▲ | 1.10▼ | 1.08▼ | 1.14▼ | N/A |
| MA100 | 1.10▼ | 1.11▼ | 1.08▼ | 4.37▼ | N/A |
| MA200 | 1.13▼ | 1.08▼ | 1.09▼ | 124.74▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | 0.003▲ | 0.003▲ | 0.037▲ | 12.514▲ |
| RSI | 47.924▼ | 48.467▼ | 48.508▼ | 44.895▼ | 36.677▼ |
| STOCH | 62.222 | 70.017 | 70.017 | 30.104 | 27.044 |
| WILL %R | -86.667▼ | -68.421 | -56.522 | -55.102 | -76.536▼ |
| CCI | -50.167 | -23.102 | -10.661 | -8.189 | 4.021 |
|
Friday, September 19, 2025 05:55 AM
Polyrizon’s PL-14 Allergy Blocker is a novel, non-invasive nasal spray that forms a physical barrier designed to provide rapid, long-lasting relief from allergic rhinitis symptoms by blocking allergen ...
|
|
Friday, September 19, 2025 05:20 AM
Polyrizon (PLRZ) announced the submission of its full pre-submission package to the U.S. Food and Drug Administration for its PL-14 product, ...
|
|
Friday, September 12, 2025 04:26 AM
Ra’anana, Israel, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 1.12 | 1.125 | 1.07 | 1.08 | 133,200 |
| 29/09/25 | 1.04 | 1.15 | 1.04 | 1.13 | 662,000 |
| 26/09/25 | 1.07 | 1.08 | 1.02 | 1.08 | 202,400 |
| 25/09/25 | 1.09 | 1.09 | 1.05 | 1.06 | 206,100 |
| 24/09/25 | 1.09 | 1.10 | 1.04 | 1.07 | 195,426 |
| 23/09/25 | 1.11 | 1.14 | 1.06 | 1.08 | 327,600 |
| 22/09/25 | 1.13 | 1.15 | 1.10 | 1.13 | 464,300 |
| 19/09/25 | 1.14 | 1.28 | 1.05 | 1.12 | 6,006,900 |
| 18/09/25 | 1.04 | 1.085 | 1.02 | 1.04 | 219,200 |
| 17/09/25 | 1.10 | 1.106 | 1.00 | 1.02 | 629,700 |
|
|
||||
|
|
||||
|
|